top of page

WEBINAR: Future Pathways for Theranostic Treatments

Wed, 31 July

|

Virtual Event

Oncothera Advocacy will be hosting an online/webinar to review our initial findings for the planned White Paper, to unite stakeholders, and to discuss effective and efficient collaborative ways to enable better patient access to Theranostic treatment. More details to come...


Registration is closed
WEBINAR: Future Pathways for Theranostic Treatments
WEBINAR: Future Pathways for Theranostic Treatments

Time & Location

31 July 2024, 6:30 pm

Virtual Event

Share this event

Thank you to our sponsors.

GenesisCare_Experts in cancer care_White_RGB_v2.png
GE_HealthCare_logo_2023-online WHT.png
Telix_Main_Logo WHT.png
GMS logo WHT.png
Siemens_Healthineers_logo.svg_WHT.png
SHIMADZU en_tagline+ia MONO_NEG.png
Radiopharma Initiative Concept v2.1 - WHT No Background.png

This initiative is made possible with a grant provided by NSW Health.

nswgov_logo_cmyk_primary_white.png
Oncothera ICON white

Oncothera Advocacy is the Voice for Theranostics

Support Us

Quick Links

Small Print

Privacy Policy

Disclaimer

​​

Site developed by
 Showoff Group.

ACNC registration logo

Oncothera Advocacy is a Registered Charity with the Australian Charities and Not–for–profit Commission.

Acknowledgement of Country

Oncothera Advocacy acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of the lands on which we live, work and connect. We pay our respects to Elders past and present, and recognise their continuing connection to land, waters, culture and community.

Commitment to Inclusion

Oncothera Advocacy is committed to an inclusive healthcare community where everyone is treated with dignity, respect and equity. We welcome and support people of all backgrounds, cultures, identities, genders and sexual orientations, including LGBTQIA+ communities.

bottom of page